Duration of analgesia after supraclavicular brachial plexus block with intravenous dexamethasone with or without dexmedetomidine: a randomised, placebo-controlled, triple-blind trial | Synapse
Duration of analgesia after supraclavicular brachial plexus block with intravenous dexamethasone with or without dexmedetomidine: a randomised, placebo-controlled, triple-blind trial
Key Points
Analgesia duration improves with intravenous dexamethasone in patients undergoing supraclavicular brachial plexus block, enhancing postoperative comfort.
Key evidence indicates significant analgesia duration compared between groups treated with dexmedetomidine and placebo.
Randomised, placebo-controlled, triple-blind trial design with two intervention groups and control.
Findings may guide clinical practices for postoperative pain management in regional anesthesia.